Vera Therapeutics, Inc. (VERA)
NASDAQ: VERA · Real-Time Price · USD
42.60
+0.55 (1.31%)
Dec 20, 2024, 4:00 PM EST - Market closed
Vera Therapeutics Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for Vera Therapeutics stock have an average target of 59.22, with a low estimate of 25 and a high estimate of 107. The average target predicts an increase of 39.01% from the current stock price of 42.60.
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 21, 2024.
Analyst Ratings
The average analyst rating for VERA stock from 9 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 3 | 3 |
| Buy | 3 | 3 | 3 | 4 | 5 | 5 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Initiates $70 | Buy | Initiates | $70 | +64.32% | Nov 21, 2024 |
| Wedbush | Wedbush | Hold Maintains $30 → $38 | Hold | Maintains | $30 → $38 | -10.80% | Nov 8, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $72 → $75 | Buy | Maintains | $72 → $75 | +76.06% | Nov 5, 2024 |
| Guggenheim | Guggenheim | Strong Buy Maintains $56 → $64 | Strong Buy | Maintains | $56 → $64 | +50.23% | Oct 28, 2024 |
| Scotiabank | Scotiabank | Buy Initiates $60 | Buy | Initiates | $60 | +40.85% | Oct 16, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.88
from -2.25
EPS Next Year
-3.21
from -2.88
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | n/a | n/a | 85.8M | |||
| Avg | n/a | n/a | 43.4M | |||
| Low | n/a | n/a | 7.7M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -2.36 | -2.33 | -2.52 | |||
| Avg | -2.88 | -3.21 | -3.48 | |||
| Low | -3.00 | -4.62 | -4.74 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.